Mia Health Holdings <7129> announced consolidated financial results for the 2nd quarter (24/4/9) of the fiscal year ending 2025/3 on the 11th. Sales increased 4.6% from the same period last year to 11.498 billion yen, operating profit increased 399.8% to 0.124 billion yen, ordinary profit increased 494.0% to 0.12 billion yen, and interim net profit attributable to parent company shareholders was 0.111 billion yen (loss of 0.032 billion yen in the same period last year).
Sales in the pharmaceutical business were 4.711 billion yen, up 3.6% from the same period last year, and segment profit increased 9.3% to 0.265 billion yen. In this interim consolidated accounting period, 1 medical mall-type pharmacy (Tachikawa-shi, Tokyo) was opened in 2024/7. As for performance, the number of prescriptions was 105.1% compared to the same period last year due to the effects of opening new stores in the previous consolidated fiscal year and the current interim consolidated fiscal period. Prescription unit prices declined due to the effects of dispensation reward revisions and drug price revisions implemented in 2024/4, but in addition to the increase in the number of prescriptions for high-cost pharmaceuticals, generic drug dispensing system addition and efforts to enhance services as a “primary pharmacy” were implemented, and efforts were made to obtain addition of technical fees, so the effects of dispensation reward revisions and drug price revisions were kept to a minimum. Note that the number of dispensing pharmacy stores at the end of this interim consolidated accounting period was 43 stores (+1 store compared to the end of the previous consolidated fiscal year).
Sales of the child-rearing support business increased 3.7% from the same period last year to 4.571 billion yen, and segment profit increased 12.7% to 0.364 billion yen. During this interim consolidated accounting period, 1 authorized nursery school and 1 school children's club were established. As for performance, the number of children attending school decreased, mainly at existing nursery schools, but in addition to an increase in the number of children in approved nursery schools established in 2024/4, the performance of school children's clubs, etc. established in 2024/4 contributed, and efforts were made to obtain additional points by arranging appropriate personnel such as nursery teachers, etc. Also, efficiency was improved due to the closure of Tokyo certified nursery schools, which were unprofitable at the end of 2024/3, so profitability was improved. Note that the number of operating establishments at the end of this interim consolidated accounting period was 79 establishments (+2 establishments compared to the end of the previous consolidated fiscal year).
Sales in the nursing care business increased 10.4% to 1.771 billion yen, and segment loss was 0.21 yen (loss of 0.085 billion yen in the same period last year). In addition to an increase in the number of users of serviced housing for the elderly (3 attached offices (1 home care support office, 1 home-visit nursing care establishment, 1 home-visit nursing care office)) of the “hospice compatible home (capacity 61 people)” established in 2023/8, sales activities aimed at acquiring the number of residents and users have continued to be strengthened, so the number of residents of serviced housing for the elderly and Sales increased as the number of users at the attached business site also remained at a high occupancy rate. Also, profitability was improved due to the closure of unprofitable establishments implemented in the previous consolidated fiscal year, and the deficit was reduced. Note that the number of nursing care establishments and facilities at the end of this interim consolidated accounting period was 65 establishments (±0 establishments compared to the end of the previous consolidated fiscal year).
Other sales (food business) increased 3.1% from the same period last year to 0.443 billion yen, and segment profit increased 65.4% to 0.009 billion yen. The performance of the school lunch sector remained sluggish due to the effects of rising prices. Also, the performance of Gin no Sara (3 stores), where the company operates stores as a franchisee, remained steady due to an increase in customer unit prices due to price revisions reflecting rising prices, although the number of customers declined due to a drop in meal delivery needs.
Regarding the full-year consolidated earnings forecast for the fiscal year ending March 31, 2025, the initial plan is unchanged, with sales rising 0.8% from the previous fiscal year to 22.9 billion yen, operating income up 24.0% to 0.49 billion yen, ordinary income up 28.3% to 0.48 billion yen, and net income attributable to parent company shareholders of 0.29 billion yen.